UNIVERSAL PINK CAR Trademark

Trademark Overview

On Wednesday, April 4, 2018, a trademark application was filed for UNIVERSAL PINK CAR with the United States Patent and Trademark Office. The USPTO has given the UNIVERSAL PINK CAR trademark a serial number of 87863129. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 10, 2022. This trademark is owned by Celularity, Inc.. The UNIVERSAL PINK CAR trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical purposes for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a canceror other disease-associated antigen; biological substances for medical use, namely, placental- derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; medical preparations that comprise placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen, for treatment of cancerand for immunotherapy; cellular immunotherapy compositions, namely, placental-derived cytotoxic T cells with a chimericantigen receptor specific for a cancer or other disease-associated antigen; andwritten instructional materials distributed in connection with the aforesaid goods
universal pink car

General Information

Serial Number87863129
Word MarkUNIVERSAL PINK CAR
Filing DateWednesday, April 4, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements

Disclaimer with Predetermined Text"CAR"
Goods and ServicesBiological preparations for medical purposes for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a canceror other disease-associated antigen; biological substances for medical use, namely, placental- derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; medical preparations that comprise placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen, for treatment of cancerand for immunotherapy; cellular immunotherapy compositions, namely, placental-derived cytotoxic T cells with a chimericantigen receptor specific for a cancer or other disease-associated antigen; andwritten instructional materials distributed in connection with the aforesaid goods

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelularity Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932
Party NameCelularity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Monday, January 10, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 16, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, May 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021EXTENSION 5 GRANTED
Tuesday, May 4, 2021EXTENSION 5 FILED
Wednesday, May 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 4, 2021TEAS EXTENSION RECEIVED
Wednesday, November 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 9, 2020EXTENSION 4 GRANTED
Monday, November 9, 2020EXTENSION 4 FILED
Monday, November 9, 2020TEAS EXTENSION RECEIVED
Thursday, October 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2020EXTENSION 3 GRANTED
Wednesday, April 1, 2020EXTENSION 3 FILED
Wednesday, April 1, 2020TEAS EXTENSION RECEIVED
Wednesday, October 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2019EXTENSION 2 GRANTED
Monday, October 7, 2019EXTENSION 2 FILED
Monday, October 7, 2019TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2019EXTENSION 1 GRANTED
Friday, April 12, 2019EXTENSION 1 FILED
Friday, April 12, 2019TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 28, 2018ASSIGNED TO LIE
Thursday, August 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 24, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 24, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 24, 2018NON-FINAL ACTION WRITTEN
Monday, July 23, 2018ASSIGNED TO EXAMINER
Thursday, April 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 7, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

pink universal antigen other disease derived placental specific cytotoxic associated receptor cells